BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 6709010)

  • 21. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
    Henseler T; Christophers E
    Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
    Marcil I; Stern RS
    Lancet; 2001 Sep; 358(9287):1042-5. PubMed ID: 11589933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis. An 8-year follow-up study.
    Tanew A; Hönigsmann H; Ortel B; Zussner C; Wolff K
    J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):960-5. PubMed ID: 3782536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The risk of melanoma in association with long-term exposure to PUVA.
    Stern RS;
    J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance.
    van de Kerkhof PC; de Rooij MJ
    Br J Dermatol; 1997 Feb; 136(2):275-8. PubMed ID: 9068750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Photochemotherapy--psoralen + UV-A (PUVA)--increased risk of cancer?].
    Harnes DK; Thune P
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):200-1. PubMed ID: 8430401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Research and development of oral psoralen and longwave radiation photochemotherapy: 2000 B.C.-1982 A.D.
    Fitzpatrick TB; Pathak MA
    Natl Cancer Inst Monogr; 1984 Dec; 66():3-11. PubMed ID: 6397691
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term photochemotherapy for psoriasis: a histopathological and clinical follow-up study with special emphasis on tumour incidence and behavior of pigmented lesions.
    Ros AM; Wennersten G; Lagerholm B
    Acta Derm Venereol; 1983; 63(3):215-21. PubMed ID: 6192634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin typing for assessment of skin cancer risk and acute response to UV-B and oral methoxsalen photochemotherapy.
    Stern RS; Momtaz K
    Arch Dermatol; 1984 Jul; 120(7):869-73. PubMed ID: 6732259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study.
    Nijsten TE; Stern RS
    J Invest Dermatol; 2003 Aug; 121(2):252-8. PubMed ID: 12880415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
    Katz KA; Marcil I; Stern RS
    J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer induction by immunosuppression in psoriasis after heavy PUVA treatment.
    Molin L; Larkö O
    Acta Derm Venereol; 1997 Sep; 77(5):402. PubMed ID: 9298142
    [No Abstract]   [Full Text] [Related]  

  • 33. Psoriasis and susceptibility to nonmelanoma skin cancer.
    Stern RS; Scotto J; Fears TR
    J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):67-73. PubMed ID: 3980806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Photochemotherapy and skin cancer. The occurrence of premalignant and malignant skin changes in patients with psoriasis treated with photochemotherapy (PUVA therapy)].
    Mørk NJ; Braathen LR; Rajka G; Hoel PS
    Tidsskr Nor Laegeforen; 1988 Mar; 108(8-9):676-8. PubMed ID: 3353970
    [No Abstract]   [Full Text] [Related]  

  • 36. 'High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer.
    Bruynzeel I; Bergman W; Hartevelt HM; Kenter CC; Van de Velde EA; Schothorst AA; Suurmond D
    Br J Dermatol; 1991 Jan; 124(1):49-55. PubMed ID: 1993145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenicity and carcinogenicity of methoxsalen plus UV-A.
    Roelandts R
    Arch Dermatol; 1984 May; 120(5):662-9. PubMed ID: 6372701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous carcinoma in psoriatic patients treated with PUVA.
    Reshad H; Challoner F; Pollock DJ; Baker H
    Br J Dermatol; 1984 Mar; 110(3):299-305. PubMed ID: 6696845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple eruptive actinic keratoses and squamous cell carcinomata following PUVA therapy of more than 11 years.
    Beiteke U; Budde J; Lentner A; Stary A; Tronnier H
    Photodermatol; 1988 Dec; 5(6):274-6. PubMed ID: 3249686
    [No Abstract]   [Full Text] [Related]  

  • 40. Carcinogenicity of combined ultraviolet B radiation and psoralen plus ultraviolet A irradiation treatment of mice.
    Granstein RD; Morison WL; Kripke ML
    Photodermatol Photoimmunol Photomed; 1992-1993 Oct; 9(5):198-202. PubMed ID: 1342188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.